Cargando…

Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya

BACKGROUND: The fetal consequences of CMV infection have made it one of the most serious infections contracted during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV infection is available during pregnancy in Kenya. Thus little is known on...

Descripción completa

Detalles Bibliográficos
Autores principales: Maingi, Zakayo, Nyamache, Anthony Kebira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247150/
https://www.ncbi.nlm.nih.gov/pubmed/25392013
http://dx.doi.org/10.1186/1756-0500-7-794
_version_ 1782346596996874240
author Maingi, Zakayo
Nyamache, Anthony Kebira
author_facet Maingi, Zakayo
Nyamache, Anthony Kebira
author_sort Maingi, Zakayo
collection PubMed
description BACKGROUND: The fetal consequences of CMV infection have made it one of the most serious infections contracted during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV infection is available during pregnancy in Kenya. Thus little is known on its epidemiological data that is necessary for health planners and care providers. METHODS: A cross sectional study was conducted at Thika district level 5 hospital, Kenya to investigate seroprevalence of CMV infections and associated possible risk factors among pregnant women. Structured questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV infections using IgG and IgM. RESULTS: Out of 260 pregnant women, 201 (77.3%) were CMV IgG 21(8.1%) CMV IgM being on acute stage of the disease. Marital status (OR = 3.7533, 95% CI =3.0231-6.9631, P < 0.0001), parity (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), and education (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), history of blood transfusion (OR = 0.0374, 95% CI = 0.00120-0.1168, OR = 0.3804) were found to significantly influence seropostivity in univariate analysis. CONCLUSION: The 88.4% CMV prevalence rate being detected among pregnant women calls for vaccine and routine screening for CMV infections and its associated risk factors in this kind of settings.
format Online
Article
Text
id pubmed-4247150
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42471502014-11-29 Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya Maingi, Zakayo Nyamache, Anthony Kebira BMC Res Notes Research Article BACKGROUND: The fetal consequences of CMV infection have made it one of the most serious infections contracted during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV infection is available during pregnancy in Kenya. Thus little is known on its epidemiological data that is necessary for health planners and care providers. METHODS: A cross sectional study was conducted at Thika district level 5 hospital, Kenya to investigate seroprevalence of CMV infections and associated possible risk factors among pregnant women. Structured questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV infections using IgG and IgM. RESULTS: Out of 260 pregnant women, 201 (77.3%) were CMV IgG 21(8.1%) CMV IgM being on acute stage of the disease. Marital status (OR = 3.7533, 95% CI =3.0231-6.9631, P < 0.0001), parity (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), and education (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), history of blood transfusion (OR = 0.0374, 95% CI = 0.00120-0.1168, OR = 0.3804) were found to significantly influence seropostivity in univariate analysis. CONCLUSION: The 88.4% CMV prevalence rate being detected among pregnant women calls for vaccine and routine screening for CMV infections and its associated risk factors in this kind of settings. BioMed Central 2014-11-12 /pmc/articles/PMC4247150/ /pubmed/25392013 http://dx.doi.org/10.1186/1756-0500-7-794 Text en © Maingi and Nyamache; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Maingi, Zakayo
Nyamache, Anthony Kebira
Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
title Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
title_full Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
title_fullStr Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
title_full_unstemmed Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
title_short Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
title_sort seroprevalence of cytomegalo virus (cmv) among pregnant women in thika, kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247150/
https://www.ncbi.nlm.nih.gov/pubmed/25392013
http://dx.doi.org/10.1186/1756-0500-7-794
work_keys_str_mv AT maingizakayo seroprevalenceofcytomegaloviruscmvamongpregnantwomeninthikakenya
AT nyamacheanthonykebira seroprevalenceofcytomegaloviruscmvamongpregnantwomeninthikakenya